Cited by 15Opioid Use Disorder TreatmentHypothalamic control of reproductive hormonesHormonal and reproductive studies

Impact of opioid therapy on gonadal hormones: focus on buprenorphine

Varma, Anjali, Sapra, Mamta, Iranmanesh, Ali·2018·Hormone Molecular Biology and Clinical Investigation

Abstract

Objective The USA is in the midst of an opioid crisis. Understanding the impact of opioids and commonly used treatments for opioid dependence is essential for clinicians and researchers in order to educate and treat the nation's growing population with opioid use disorders. As a relatively new treatment for opioid dependence, buprenorphine is gaining popularity to the extent of becoming not only a preferred approach to the maintenance of opiate addiction, but also an option for chronic pain management. The purpose of this report is to review the available evidence on the endocrine effects of buprenorphine, particularly as it relates to the hypothalamic-pituitary-gonadal (HPG) axis, which is controversial and not fully defined. Method We conducted a Pubmed search (2000-2017) for human studies in the English language for articles that were available as full length regarding buprenorphine, endocrinopathy, hypogonadism, bone density, opioids. Case reports were also reviewed, although prospective studies and randomized controlled trials received more weight. Results Opioid induced hypogonadism is well established. Most studies report that buprenorphine being a partial agonist/antagonist may not be impacting the pituitary trophic hormones as much. There are reports of sexual dysfunction in subjects maintained on buprenorphine, some without hormonal correlation. Thus with the understanding that pertinent clinical studies are limited in number, varied in methodology, mostly cross sectional, predominantly in men and small number of participants, more research in this area is warranted. Conclusion Based on a comprehensive review of the available literature, we conclude that despite its increasing popularity, buprenorphine has not been adequately studied in respect to its long-term effects on the hypothalamic-pituitary-adrenal (HPA) axis. There is a great need for longitudinal systematic trials to define the potential buprenorphine-induced endocrine consequences.

Integrity signals

Registry

Crossref · 10.1515/hmbci-2017-0080

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

We couldn’t retrieve this paper’s full text, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Cites

Flagged first, then by citations

Cited by

Sorted by citations

Authors
Varma, A., Sapra, M., & Iranmanesh, A.
Affiliations
Veterans Health Administration (US)
Corresponding author
Varma, Anjali
Venue
Hormone Molecular Biology and Clinical Investigation
Published
2018-02-17
Volume
36
Issue
2
ISSN
  • 1868-1883 (ISSN-L)
  • 1868-1891
OpenAlex
W2790656516
Cited by
15
References
4
Citations by year
2026: 1 · 2024: 2 · 2022: 4 · 2021: 1 · 2020: 2 · 2019: 5
FWCI
0.36
Type
journal article
Language
en
Open access
closed
Locations
  • Hormone Molecular Biology and Clinical Investigation (publishedVersion)
  • PubMed (publishedVersion)
Topics
  • Health Sciences › Medicine › Public Health, Environmental and Occupational Health › Opioid Use Disorder Treatment
  • Health Sciences › Medicine › Reproductive Medicine › Hypothalamic control of reproductive hormones
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Hormonal and reproductive studies
Keywords
buprenorphine, opioid use disorder, opioid dependence treatment, hypothalamic-pituitary-gonadal axis, hypogonadism, gonadal hormones, sexual dysfunction, bone mineral density, opioid epidemic, chronic pain management
MeSH terms
Animals, Buprenorphine, Gonads, Humans, Hypothalamo-Hypophyseal System, Narcotic Antagonists, Pituitary-Adrenal System, Gonadal Hormones, Opiate Substitution Treatment

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review